Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs. (2005). Guidance for industry: Potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Drug Evaluation and Research (U.S.). Office of Generic Drugs. Guidance for Industry: Potassium Chloride Modified-release Tablets and Capsules, in Vivo Bioequivalence and in Vitro Dissolution Testing. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2005.
MLA (9th ed.) CitationCenter for Drug Evaluation and Research (U.S.). Office of Generic Drugs. Guidance for Industry: Potassium Chloride Modified-release Tablets and Capsules, in Vivo Bioequivalence and in Vitro Dissolution Testing. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2005.